通天口服液治疗椎基底动脉供血不足临床分析  

Clinical analysis for treat Vertebrobasilar insufficiency patients use Tongtian oral liquid

作　　者：王剑威[1] 朱蔚文[1] 

机构地区：[1]广州医学院附属第二医院,广东广州510260

出　　处：《临床医药实践》2007年第4期253-254,共2页Proceeding of Clinical Medicine

摘　　要：目的:探讨通天口服液治疗椎基底动脉供血不足(VB I)的临床疗效。方法:应用通天口服液治疗VB I 62例,与32例普通治疗对照组对比,观察治疗前后两组症状、体征及纤维蛋白原等的改变。结果:治疗组起效时间、临床疗效明显优于对照组,有高度统计学意义(P<0.01)。结论:通天口服液具有降黏、去纤、抗凝、解聚的作用,是治疗VB I的必然选择。Objective：Approach the clinic therapeutic effect of Tongtian oral liquid treated vertebrabasilar insuffi ciency patients. Methods：To make use of Tongtian oral liquid treated 62 vertebrabasilar insufficiency patients,con trast with 32 common treated control group. To observe symptom,signs,lower fibrinogen during two group. Results Effect time and clinical curative effect of treated group obviously outstrip control group. It have high statistical signifi cance （P~ 0.01 ）. Conclusion ： The Tongtian oral liquid has kataglutinous, dedelicate, anticoagulation, depolymd effec tive. It is necessarily selection to treat vertebrobasilar insufficiency.

关 键 词：通天口服液 椎-基底动脉供血不足(VBI) 分析 

分 类 号：R743[医药卫生—神经病学与精神病学]